THURSDAY, March 11, 2021 (HealthDay News) — There is no evidence that a promising gene therapy for sickle cell disease triggered leukemia in a patient, according to the company testing the experimental treatment. Bluebird Bio announced a few weeks ago that a sickle cell patient treated with the gene therapy five years ago in a...